Discover
PSTV
Plus Therapeutics, Inc.
4.16
2 x 3.16
2 x 5.40
bid
ask
-
0.21
4.81%
2 @ 04:00 PM
4.20 +0.04 (0.96%)
| Ytd | -67.37% | |
| 1y | -46.32% |
4.15
day range
4.51
2.90
52 week range
23.50
| Open | 4.39 | Prev Close | 4.37 | Low | 4.15 | High | 4.51 | Mkt Cap | 28.64M |
| Vol | 138.55K | Avg Vol | 310.20K | EPS | 21.56 | P/E | 0.19 | Forward P/E | -0.52 |
| Beta | 0.69 | Short Ratio | 0.98 | Inst. Own | 11.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-04 | 50-d Avg | 5.61 | 200-d Avg | 9.60 | 1yr Est | 15.75 |
| Income Statement | |||
| Total Revenue | 1.03M | ||
| Revenues (USD) | 1.03M | ||
| Gross Profit | 1.03M | ||
| Operating Expenses | 8.15M | ||
| Research and Development Expense | 2.87M | ||
| Selling, General and Administrative Expense | 5.28M | ||
| Operating Income | -7.12M | ||
| Interest Expense | 17.00K | ||
| Net Income | -6.95M | ||
| Net Income Common Stock | -6.95M | ||
| Net Income Common Stock (USD) | -6.95M | ||
| Consolidated Income | -6.95M | ||
| Earnings per Basic Share | -1.05 | ||
| Earnings per Basic Share (USD) | -1.05 | ||
| Earnings per Diluted Share | -1.05 | ||
| Earning Before Interest & Taxes (EBIT) | -6.93M | ||
| Earning Before Interest & Taxes (USD) | -6.93M | ||
| Weighted Average Shares | 6.65M | ||
| Weighted Average Shares Diluted | 6.65M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.02M | ||
| Cash and Equivalents (USD) | 3.02M | ||
| Investments | 12.09M | ||
| Investments Current | 12.09M | ||
| Trade and Non-Trade Receivables | 1.35M | ||
| Current Assets | 18.03M | ||
| Property, Plant & Equipment Net | 1.07M | ||
| Total Assets | 19.92M | ||
| Debt Current | 725.00K | ||
| Total Debt | 725.00K | ||
| Current Liabilities | 7.96M | ||
| Total Liabilities | 7.96M | ||
| Accumulated Retained Earnings (Deficit) | -522.81M | ||
| Shareholders Equity | 11.96M | ||
| Shareholders Equity (USD) | 11.96M | ||
| Assets Non-Current | 1.89M | ||
| Total Debt (USD) | 725.00K | ||
| Goodwill and Intangible Assets | 671.00K | ||
| Trade and Non-Trade Payables | 6.16M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 109.00K | ||
| Net Cash Flow from Financing | 9.04M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.74M | ||
| Capital Expenditure | -818.00K | ||
| Issuance (Purchase) of Equity Shares | 13.64M | ||
| Issuance (Repayment) of Debt Securities | -100.00K | ||
| Net Cash Flow from Investing | -8.53M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -7.71M | ||
| Net Cash Flow from Operations | -6.24M | ||
| Share Based Compensation | 1.02M | ||